Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era

The prognostic value of serum beta-2 microglobulin for diffuse large B-cell lymphoma (DLBCL) is not well known in the rituximab era. A retrospective registry data analysis of 833 patients with de novo DLBCL treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Seo, Seyoung, Hong, Jung Yong, Yoon, Shinkyo, Yoo, Changhoon, Park, Ji Hyun, Lee, Jung Bok, Park, Chan-sik, Huh, Jooryung, Lee, Yoonse, Kim, Kyung Won, Ryu, Jin-Sook, Kim, Seok Jin, Kim, Won Seog, Yoon, Dok Hyun, Suh, Cheolwon
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363560/
https://ncbi.nlm.nih.gov/pubmed/27764777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12734
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares